iBio Inc (IBIO)
1.98
+0.17
(+9.39%)
USD |
NYAM |
May 17, 16:00
1.98
0.00 (0.00%)
After-Hours: 20:00
iBio 1 Year Total Returns (Daily): -89.71% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 17, 2024 | -89.71% |
May 16, 2024 | -90.27% |
May 15, 2024 | -90.02% |
May 14, 2024 | -90.69% |
May 13, 2024 | -91.01% |
May 10, 2024 | -91.27% |
May 09, 2024 | -91.38% |
May 08, 2024 | -91.20% |
May 07, 2024 | -90.83% |
May 06, 2024 | -90.87% |
May 03, 2024 | -90.87% |
May 02, 2024 | -90.77% |
May 01, 2024 | -91.51% |
April 30, 2024 | -92.08% |
April 29, 2024 | -92.31% |
April 26, 2024 | -91.93% |
April 25, 2024 | -92.77% |
April 24, 2024 | -91.95% |
April 23, 2024 | -92.69% |
April 22, 2024 | -93.15% |
April 19, 2024 | -93.38% |
April 18, 2024 | -91.81% |
April 17, 2024 | -90.74% |
April 16, 2024 | -90.80% |
April 15, 2024 | -90.90% |
Date | Value |
---|---|
April 12, 2024 | -90.38% |
April 11, 2024 | -91.27% |
April 10, 2024 | -91.22% |
April 09, 2024 | -91.18% |
April 08, 2024 | -90.81% |
April 05, 2024 | -91.35% |
April 04, 2024 | -91.64% |
April 03, 2024 | -91.35% |
April 02, 2024 | -93.12% |
April 01, 2024 | -91.95% |
March 28, 2024 | -91.29% |
March 27, 2024 | -93.09% |
March 26, 2024 | -97.26% |
March 25, 2024 | -97.39% |
March 22, 2024 | -97.34% |
March 21, 2024 | -97.80% |
March 20, 2024 | -97.71% |
March 19, 2024 | -97.27% |
March 18, 2024 | -97.29% |
March 15, 2024 | -97.15% |
March 14, 2024 | -96.71% |
March 13, 2024 | -96.86% |
March 12, 2024 | -96.91% |
March 11, 2024 | -96.86% |
March 08, 2024 | -96.99% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-97.80%
Minimum
Mar 21 2024
1.36K%
Maximum
Nov 19 2020
18.32%
Average
-68.97%
Median
Jan 20 2022
1 Year Total Returns (Daily) Benchmarks
Lixte Biotechnology Holdings Inc | -62.14% |
PAVmed Inc | -74.06% |
Avalo Therapeutics Inc | -98.57% |
Imunon Inc | 6.06% |
Ocugen Inc | 175.9% |